placental growth factor; PlGF (PGF, PGFL, PLGF)
Jump to navigation
Jump to search
Function
- growth factor active in angiogenesis & endothelial cell growth, stimulating their proliferation & migration.
- controls blood vessel formation & permeability through interactions with two endothelial tyrosine kinase receptors: FLT1 & KDR/FLK1
- PlGF-2 binds NRP1/neuropilin-1 & NRP2/neuropilin-2 (heparin-dependent)
- forms heterodimer with VEGFA/VEGF
- isoform PlGF-3 is found both as homodimer & as monomer
Structure
- N-glycosylated
- antiparallel homodimer; disulfide-linked
- isoform PlGF-2 contains a basic insert which acts as a cell retention signal
- belongs to the PDGF/VEGF growth factor family
Compartment
Alternative splicing
- named isoforms=3; PlGF-1, PlGF-2, PlGF-3
Expression
- present in most placental tissues
- PlGF-2 is specific to early (8 week) placenta
- only PlGF-1 is found in the colon & mammary carcinomas
Pathology
- plasma placental growth factor levels are decreased in women with pre-eclampsia[2]
Laboratory
More general terms
Additional terms
- vascular endothelial growth factor receptor 1; VEGFR-1; vascular permeability factor receptor; tyrosine-protein kinase receptor FLT; Flt-1; tyrosine-protein kinase FRT; Fms-like tyrosine kinase 1 (FLT1, FLT, FRT)
- vascular endothelial growth factor receptor 2; VEGFR-2; kinase insert domain receptor; protein-tyrosine kinase receptor Flk-1; CD309 (KDR, FLK1)
References
- ↑ UniProt http://www.uniprot.org/uniprot/P49763.html
- ↑ 2.0 2.1 Zeisler H et al Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med 2016; 374:13-22. January 7, 2016 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26735990 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1414838
Seely EW, Solomon CG Improving the Prediction of Preeclampsia N Engl J Med 2016; 374:83-84. January 7, 2016 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26735997 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMe1515223